Lung cancer screening

IASLC World Conference on Lung Cancer--Summary of the Presidential Symposium Research

Retrieved on: 
Monday, September 9, 2019
Cancer, Medicine, Health, Health effects of tobacco, Cancer screening, Lung cancer screening, Lung cancer, CT scan, National Lung Screening Trial, Cancer prevention

BARCELONA, Spain, Sept. 9, 2019 /PRNewswire/ -- Note:This is a summary of research presented this morning at the International Association for the Study of Lung Cancer's World Conference on Lung Cancer.

Key Points: 
  • BARCELONA, Spain, Sept. 9, 2019 /PRNewswire/ -- Note:This is a summary of research presented this morning at the International Association for the Study of Lung Cancer's World Conference on Lung Cancer.
  • A combination of the EarlyCDT-Lung Test followed by CT imaging in Scottish patients at risk for lung cancer resulted in a significant decrease in late-stage diagnosis of lung cancer and may decrease lung cancer mortality.
  • Lung cancer screening efforts have accelerated in the last decade, with researchers showing that low-dose CT screening is effective in reducing lung cancer mortality.
  • The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies.

IASLC World Conference on Lung Cancer--Summary of the Presidential Symposium Research

Retrieved on: 
Monday, September 9, 2019
Cancer, Medicine, Health, Health effects of tobacco, Cancer screening, Lung cancer screening, Lung cancer, CT scan, National Lung Screening Trial, Cancer prevention

BARCELONA, Spain, Sept. 9, 2019 /PRNewswire/ -- Note:This is a summary of research presented this morning at the International Association for the Study of Lung Cancer's World Conference on Lung Cancer.

Key Points: 
  • BARCELONA, Spain, Sept. 9, 2019 /PRNewswire/ -- Note:This is a summary of research presented this morning at the International Association for the Study of Lung Cancer's World Conference on Lung Cancer.
  • A combination of the EarlyCDT-Lung Test followed by CT imaging in Scottish patients at risk for lung cancer resulted in a significant decrease in late-stage diagnosis of lung cancer and may decrease lung cancer mortality.
  • Lung cancer screening efforts have accelerated in the last decade, with researchers showing that low-dose CT screening is effective in reducing lung cancer mortality.
  • The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies.

Eon Announces Initiative to Offer Qualified Lung Cancer Screening Programs CMS Compliance Verification

Retrieved on: 
Wednesday, September 4, 2019
Federal assistance in the United States, Healthcare reform in the United States, Presidency of Lyndon B. Johnson, Health, Lung cancer, Cancer screening, Lung cancer screening, American College of Radiology, Medicare, Medicaid, Centers for Medicare and Medicaid Services, Compliance

DENVER, Sept. 4, 2019 /PRNewswire/ -- Eon , a Denver-based healthcare technology company, offers free Centers for Medicare & Medicaid Services (CMS) compliance audits to qualifying lung cancer screening programs in the United States.

Key Points: 
  • DENVER, Sept. 4, 2019 /PRNewswire/ -- Eon , a Denver-based healthcare technology company, offers free Centers for Medicare & Medicaid Services (CMS) compliance audits to qualifying lung cancer screening programs in the United States.
  • Currently, the only approved CMS registry is the American College of Radiology's (ACR) Lung Cancer Screening Registry (LCSR).
  • For these reasons, there's a low rate of CMS compliance for lung screening programs nationwide.
  • To see if your lung screening program qualifies for a free CMS compliance check, please call Eon directly at (303) 578-8393 or visit Eon to request more information .

Software Company, Eon, Introduces Initiative to Help Qualified Lung Cancer Screening Programs Across the United States Reach 100% CMS Compliance for Free

Retrieved on: 
Wednesday, September 4, 2019
Federal assistance in the United States, Healthcare reform in the United States, Presidency of Lyndon B. Johnson, Health, Cancer screening, Lung cancer, Lung cancer screening, Medicaid, Medicare, American College of Radiology, Centers for Medicare and Medicaid Services

DENVER, Sept. 4, 2019 /PRNewswire/ -- Eon , a Denver-based healthcare technology company, offers free Centers for Medicare & Medicaid Services (CMS) compliance audits to qualifying lung cancer screening programs in the United States.

Key Points: 
  • DENVER, Sept. 4, 2019 /PRNewswire/ -- Eon , a Denver-based healthcare technology company, offers free Centers for Medicare & Medicaid Services (CMS) compliance audits to qualifying lung cancer screening programs in the United States.
  • A 2015 Decision Memo by the Centers for Medicare & Medicaid Services approved reimbursement for lung cancer screening for eligible at-risk populations.
  • Currently, the only approved CMS registry is the American College of Radiology's (ACR) Lung Cancer Screening Registry (LCSR).
  • For these reasons, there's a low rate of CMS compliance for lung screening programs nationwide.

VisionGate Announces an Exclusive Global License, Manufacturing and Supply Agreement for Iloprost, VisionGate’s Phase 2 Oral Lung Cancer Interception Drug

Retrieved on: 
Thursday, August 22, 2019
Lung cancer, Neoplasms, RTT, Cancer screening, Lung cancer screening, Oncology, Cancer, Epidemiology of cancer

If confirmed in additional trials, this remarkable result would translate into a significant impact in preventing lung pre-cancer from progressing to cancer, thus reducing lung cancer incidence.

Key Points: 
  • If confirmed in additional trials, this remarkable result would translate into a significant impact in preventing lung pre-cancer from progressing to cancer, thus reducing lung cancer incidence.
  • VisionGate remains on track for an FDA meeting to finalize the clinical study protocol and approval path for Iloprost, the first oral lung cancer interception drug.
  • The Iloprost oncology development program is part of VisionGates mission to develop a new treatment paradigm for lung cancer interception and prevention.
  • 3Wilbur, et.al., Automated 3-Dimensional Morphologic Analysis of Sputum Specimens for Lung Cancer Detection: Performance Characteristics Support Use in Lung Cancer Screening,Cancer Cytopathology.

Market Leader for Patient Identification and Tracking Software, EonDirect, Expands to Abdominal Aortic Aneurysm

Retrieved on: 
Thursday, August 1, 2019
Medicine, Medical specialties, Angiology, Vascular surgery, Medical terminology, IgG4-related disease, Vascular diseases, Screening, Aortic aneurysm, Lung cancer screening, Aneurysm, Abdominal aortic aneurysm

However, keyword search alone, when applied to identification of incidental findings, results in significantly higher false positive rates.

Key Points: 
  • However, keyword search alone, when applied to identification of incidental findings, results in significantly higher false positive rates.
  • Therefore, Eon takes standard NLP further by using natural language processing outputs to build the EonEndu deep learning models.
  • EonDirectis the market leader for lung cancer screening management and is expanding its proven platform to additional disease states.
  • EonEndu + EonDirect now identify and track both lung cancer and abdominal aortic aneurysm populations, greatly impacting patient outcomes and benefitting hospital systems.

Lung Cancer Screening Awareness Campaign Focuses on At-Risk Kentuckians

Retrieved on: 
Monday, June 10, 2019
Lung cancer, Health, Bonnie J. Addario Lung Cancer Foundation, Lung Cancer Alliance, Neoplasms, Cancer, Lung cancer screening, Addario Lung Cancer Medical Institute

LEXINGTON, Ky., June 10, 2019 /PRNewswire/ -- GO2 Foundation for Lung Cancer (formerly known as Lung Cancer Alliance and the Bonnie J. Addario Lung Cancer Foundation) is conducting a statewide education campaign in partnership with the University of Kentucky bringing lung cancer screening awareness to the thousands of Kentuckians at risk for the disease.

Key Points: 
  • LEXINGTON, Ky., June 10, 2019 /PRNewswire/ -- GO2 Foundation for Lung Cancer (formerly known as Lung Cancer Alliance and the Bonnie J. Addario Lung Cancer Foundation) is conducting a statewide education campaign in partnership with the University of Kentucky bringing lung cancer screening awareness to the thousands of Kentuckians at risk for the disease.
  • The campaign stems from the Kentucky LEADS Collaborative (Lung Cancer, Education, Awareness, Detection, Survivorship), a project led by the University of Kentucky (UK), University of Louisville (UofL), and the GO2 Foundation for Lung Cancer.
  • As part of the Kentucky LEADS effort to reduce lung cancer in the state, educational ads are airing in cable television markets throughout the state, urging current and former heavy smokers 55 years and older to talk to a clinician about lung cancer screening.
  • Founded by patients and survivors, GO2 Foundation for Lung Cancer (a merger between Lung Cancer Alliance and the Bonnie J. Addario Lung Cancer Foundation) transforms survivorship as the world's leading organization dedicated to saving, extending, and improving the lives of those vulnerable, at risk, and diagnosed with lung cancer.

The Eon Expert Series: Defying Lung Cancer with Eon + Mark Cuban

Retrieved on: 
Friday, May 17, 2019
Lung cancer, Medicine, RTT, Health, Clinical medicine, Cancer screening, Lung cancer screening, Pulmonology, Cancer, Screening

Eon is excited to bring top minds together to answer the tough questions and discuss innovative healthcare solutions and the patient impact they could have.

Key Points: 
  • Eon is excited to bring top minds together to answer the tough questions and discuss innovative healthcare solutions and the patient impact they could have.
  • He has experience in evaluating new technologies for the diagnosis and staging of lung cancer.
  • Peter Mazzone MD, FCCP is a pulmonologist at the Cleveland Clinic where he directs the Lung Cancer Program for the Respiratory Institute and the Lung Cancer Screening Program for the hospital system.
  • He has served within Chest and the American Thoracic Society to lead policy development projects related to quality metrics for the evaluation of lung cancer, components necessary for high-quality lung cancer screening, and the clinical application of molecular biomarkers for lung cancer detection.

Thynk Health Raises $2.2 Million and Expands Executive Leadership

Retrieved on: 
Tuesday, January 8, 2019
Medicine, Lung cancer, Medical terminology, Prevention, Cancer screening, Lung cancer screening, Screening, Health

This investment afforded Thynk Health the opportunity to continue to build out their leadership team, with the addition of seasoned executives to lead the company through an era of expansion and further innovation.

Key Points: 
  • This investment afforded Thynk Health the opportunity to continue to build out their leadership team, with the addition of seasoned executives to lead the company through an era of expansion and further innovation.
  • At Thynk Health we achieve that by adding efficiencies to LDCT screening programs and patient follow up.
  • I'm really excited to be a part of the young, dynamic software team here at Thynk Health.
  • The Thynk Health platform optimizes data-driven workflows and provides operational and clinical analytics for lung cancer screening programs and other quality initiatives.

Stand Up To Cancer, American Cancer Society, Genentech And Rally Health Aim to Increase Earlier Cancer Detection Through Annual "Cancer Screen Week" Initiative

Retrieved on: 
Wednesday, December 5, 2018
Cancer, RTT, Health, Epidemiology of cancer, Lung cancer screening

According to the American Cancer Society, almost 610,000 people are expected to die from cancer in 2018.

Key Points: 
  • According to the American Cancer Society, almost 610,000 people are expected to die from cancer in 2018.
  • Cancer screening increases the chances of catching certain cancers early, when they are most likely to be treated successfully.
  • Every pledge increases the potential impact "Cancer Screen Week" can have on saving more lives from cancer.
  • The American Cancer Society does not have guidelines for the early detection of skin cancer.